Our Pricing

Weight Loss Pens Discount Code - Save 10% Today

Published on: June 03, 2026

Searching for a weight loss pens discount code UK that delivers genuine savings? At Cured Pharmacy, you'll save 10% on UK-licensed weight loss injection pens including Mounjaro, Wegovy, and Saxenda, with transparent upfront pricing and free clinical consultations completed in under three minutes. All prescription weight loss pens require assessment by our UK-registered prescribers before dispensing.

How Weight Loss Injection Pens Work

Weight loss injection pens deliver GLP-1 receptor agonists or dual GIP/GLP-1 agonists subcutaneously, mimicking natural hormones that regulate appetite and blood sugar metabolism [1]. These medications slow gastric emptying, increase feelings of fullness, and reduce food cravings through direct action on hypothalamic appetite centres.

Clinical trials demonstrate that GLP-1 treatments produce significantly greater weight reduction than lifestyle modification alone. The STEP trials showed semaglutide achieving average body weight reductions of 14.9% over 68 weeks, whilst the SURPASS-3 trial demonstrated tirzepatide achieving up to 22.5% average reduction over 72 weeks [1][2]. These results represent the most effective pharmacological weight management options currently licensed in the UK by the MHRA.

Weight Loss Pens Available with Discount Code UK

At Cured Pharmacy, our weight loss pens discount code UK applies to all prescription injection treatments following clinical assessment. Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist, offering superior weight reduction compared to single-pathway alternatives in head-to-head trials [3]. Wegovy and Saxenda both contain semaglutide-class medications but differ in dosing frequency and formulation strength.

Each treatment requires weekly or daily subcutaneous injection using pre-filled pens designed for home use. Our UK prescribers assess your medical history, current medications, BMI, and weight management goals during your free online consultation to determine the most suitable option. All pens come with comprehensive patient information leaflets and injection technique guidance.

Choosing Between Injection Frequencies

Weekly injection pens like Mounjaro and Wegovy offer convenience for patients who prefer less frequent administration, whilst daily options like Saxenda provide more gradual dose titration. Your UK prescriber will discuss your lifestyle preferences, previous treatment experience, and any needle anxiety during your consultation to recommend the optimal frequency pattern for sustainable adherence.

Clinical Evidence for Weight Loss Injection Pens

The SURPASS clinical trial programme evaluated tirzepatide across multiple dosing strengths in over 6,000 participants with obesity or overweight with weight-related comorbidities [1]. At the highest licensed dose, participants achieved average weight reductions exceeding 22% of baseline body weight, with 63% of participants achieving at least 20% weight loss — substantially higher than comparator treatments.

Semaglutide's efficacy was established through the STEP trial series, where 2.4mg weekly dosing produced average weight loss of 14.9% compared to 2.4% with placebo over 68 weeks [2]. Importantly, weight loss was accompanied by improvements in cardiovascular risk markers including blood pressure, lipid profiles, and inflammatory markers. These trials required participants to combine medication with reduced-calorie diet and increased physical activity, reflecting real-world clinical practice recommendations.

Long-Term Safety Data

Extension studies demonstrate that weight loss is maintained with continued treatment, whilst discontinuation typically results in gradual weight regain [4]. Common side effects include gastrointestinal symptoms such as nausea, diarrhoea, and constipation, which generally diminish with continued use. Serious adverse events remain rare, but all GLP-1 treatments carry specific contraindications including personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2.

How to Use Your Weight Loss Pens Discount Code UK

Your discount applies automatically during checkout after completing your free online consultation with our UK-registered prescribers. The assessment covers your medical history, current medications, allergies, and weight management goals, typically taking under three minutes to complete. Our clinical team reviews your responses within hours, and if approved, your prescription is dispensed from our UK-registered pharmacy and dispatched in discreet packaging.

Pricing remains transparent before you begin your consultation — there are no hidden fees or subscription requirements. Your discount code UK applies to your first order, with competitive ongoing pricing for continuation supplies. We guarantee the lowest prices in the UK for genuine licensed medications, with all products sourced through regulated UK pharmaceutical wholesalers.

Starting Your Weight Loss Injection Treatment

All weight loss injection pens require gradual dose escalation to minimise gastrointestinal side effects and improve tolerability [5]. Your prescriber will specify your starting dose, which is typically increased every four weeks until reaching your maintenance dose. This titration schedule allows your body to adapt to the medication whilst monitoring for any adverse effects.

You'll receive detailed injection technique instructions with your first supply, including guidance on injection sites (abdomen, thigh, or upper arm), needle disposal, and pen storage requirements. Most patients find subcutaneous injection straightforward after the first few administrations. Our pharmacy team remains available via phone during business hours if you have questions about injection technique or experience any unexpected symptoms.

Monitoring and Follow-Up

Regular follow-up with your prescriber ensures treatment remains appropriate and effective. We recommend monitoring your weight, blood pressure, and any side effects throughout treatment. Your prescriber may adjust your dose based on your response and tolerability. Continuation prescriptions require periodic reassessment to confirm ongoing clinical appropriateness and discuss progress towards your weight management goals.

Weight Loss Pens vs Oral Alternatives

Injectable GLP-1 treatments demonstrate superior efficacy compared to oral weight loss medications in clinical trials [6]. Orlistat, the most commonly prescribed oral option, works through fat absorption inhibition and produces average weight loss of 3-5% compared to 15-22% with injection pens. However, oral medications may suit patients with needle phobia or those seeking lower-cost alternatives.

The choice between injection pens and oral treatments depends on your weight loss goals, medical history, budget considerations, and personal preferences. Our UK prescribers discuss all licensed options during your consultation, ensuring you understand the expected outcomes, side effect profiles, and costs associated with each treatment. Some patients begin with oral medications before progressing to injections if additional efficacy is needed.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Frias, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
5. Davies, M., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
6. Khera, R., et al. (2016). Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events. JAMA, 315(22), 2424–2434. https://doi.org/10.1001/jama.2016.7602 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to diet, exercise, and medication regimens.